SEC's Theranos Probe Shows Unicorn Hunt Not A Myth

The news that blood-testing company Theranos Inc. is under investigation by the U.S. Securities and Exchange Commission offers the latest proof that the Wall Street regulator has its sights trained on...

Already a subscriber? Click here to view full article